Stocks ended higher Wednesday as tensions between the US and Iran appear to have eased after the Islamic Republic's rocket attacks overnight on military...
Price: 231.58, Change: +7.79, Percent Change: +3.48 ...
Price: 228.76, Change: +4.97, Percent Change: +2.22 ...
Stocks ended higher on Monday, recovering from Friday's selloff over geopolitical concerns after the US military killed Iran's top military commander...
| Address | 50 Northern Avenue Boston, Massachusetts 02210 |
| Phone | +1.617.341.6100 |
| Number of Employees | 2,500 |
| Recent SEC Filing | 01/17/2020 4 |
| Chairman, President & Chief Executive Officer | Jeffrey M. Leiden |
| Chief Financial Officer & Executive Vice President | Charles F. Wagner |
| Chief Scientific Officer & EVP-Global Research | David Matthew Altshuler |
| Chief Medical Officer & Executive Vice President | Reshma Kewalramani |
| Price Open | $235.84 |
| Previous Close | $235.83 |
| 52 Week Range | $163.68 - 237.20 |
| Market Capitalization | $60.3 B |
| Shares Outstanding | 257.1 M |
| Sector | Health Technology |
| Industry | Biotechnology | Next Earnings Announcement | 02/04/2020 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | 28.59 |
| Earnings per Share | $8.28 |
| Beta vs. S&P 500 | N/A |
| Revenue | $3.0 B |
| Net Profit Margin | 59.75% |
| Return on Equity | 44.02% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
